Toxikon News and Announcements

Toxikon Opens European Business Center in the Netherlands

Toxikon is pleased to announce that effective 1 September 2018, it is reopening its European office in Almelo, The Netherlands, to better support our growing and existing European customers, which began with Toxikon Europe over 28 years ago. A dedicated client relations and sample management team will offer localized service for sponsors throughout Europe, including project quoting, management of testing programs, and sample management and shipping. The Almelo office will offer the same personalized service and superior turn-around times Toxikon’s European clients have come to rely upon. Toxikon continues to deliver services throughout the world in over 60 countries. 

For more information, please contact us or call +1 800-458-4141.

Toxikon News and Announcements
preclinical contract research, contract research organization, CRO, safety testing, efficacy testing, medical device testing, pharmaceutical testing, drug research and development
Toxikon is a leading preclinical contract research organization providing in vivo, in vitro, and analytical testing services for the pharmaceutical, biotechnology, and medical device industries – helping those companies gain approval for their products quickly and bring them to market successfully.